JONA STEAD: Open Payments
NPI 1891141552 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 67 payments from 19 companies in 2025. Trend: 2023 $585 · 2024 $997 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $268 |
| PFIZER INC. | 13 | $214 |
| AstraZeneca Pharmaceuticals LP | 4 | $136 |
| GlaxoSmithKline, LLC. | 6 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| Almatica Pharma LLC | 4 | $71 |
| Abbott Laboratories | 3 | $64 |
| Lilly USA, LLC | 4 | $63 |
| ABBVIE INC. | 4 | $62 |
| Amgen Inc. | 3 | $49 |
Products named: AIRSUPRA, ELIQUIS, Wegovy, Ozempic, NURTEC ODT, JARDIANCE, LOREEV XR, TRELEGY ELLIPTA.
Industry payments across NV — which companies pay providers there.
